In this issue of Clinics in Liver Disease, guest editor Mitchell L Shiffman brings considerable expertise to the topic of Challenging Issues in the Management of Chronic Hepatitis B Virus.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Changing Demographics of Hepatitis B Virus Infection - p. 673 9. Interpretation of HBV Serologies - p. 689 10. Treatment and Prevention of Acute Hepatitis B Virus - p. 711 11. Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy - p. 725 12. Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa - p. 741 13. Controversies in Treating Chronic Hepatitis B virus: The Role of Hepatitis B Virus DNA and Surface Antigen Titer - p. 763 14. Controversies in the Management of Hepatitis B: Hepatocellular Carcinoma - p. 785 15. Controversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic Results - p. 805 16. Chronic Hepatitis B Virus in Patients with Chronic Hepatitis C Virus - p. 817 17. New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection - p. 831 18. Use of Hepatitis B Virus–Positive Organs in Organ Transplantation - p. 841 19. Hepatitis B and Health Care Workers - p. 859 20. Novel Therapies That May Cure Chronic Hepatitis B Virus - p. 875
In this issue of Clinics in Liver Disease, guest editor Mitchell L Shiffman brings considerable expertise to the topic of Challenging Issues in the Management of Chronic Hepatitis B Virus.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Changing Demographics of Hepatitis B Virus Infection - p. 673 9. Interpretation of HBV Serologies - p. 689 10. Treatment and Prevention of Acute Hepatitis B Virus - p. 711 11. Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy - p. 725 12. Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa - p. 741 13. Controversies in Treating Chronic Hepatitis B virus: The Role of Hepatitis B Virus DNA and Surface Antigen Titer - p. 763 14. Controversies in the Management of Hepatitis B: Hepatocellular Carcinoma - p. 785 15. Controversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic Results - p. 805 16. Chronic Hepatitis B Virus in Patients with Chronic Hepatitis C Virus - p. 817 17. New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection - p. 831 18. Use of Hepatitis B Virus–Positive Organs in Organ Transplantation - p. 841 19. Hepatitis B and Health Care Workers - p. 859 20. Novel Therapies That May Cure Chronic Hepatitis B Virus - p. 875
